Market report: Biotechs up for third week in a row
27 November, 2010 by David BinningThe S&P/ASX 200 Heathcare Index closed in the black on Friday for the third week in a row, as the wider market slipped for the second week in a row.
R&D Tax Credit bill passes lower house
22 November, 2010 by David BinningLike a spent fighter coming back from the brink after teetering on the ropes in the dying stages, the federal government’s R&D Tax Credit bill is still standing at the 12th round bell with only one more round to go.
Professor Frank Fenner dies aged 95
22 November, 2010 by Staff WritersAustralian scientists today paid tribute to the distinguished life and career of Professor Frank Fenner AC, MBE who passed away today aged 95.
Opinion: Business hit by R&D Tax Credit uncertainty
17 November, 2010 by Staff WritersTwelve months after the release of the initial draft of the R&D Tax Credit, a series of false starts, contested claims and last minute legislative changes have seen the proposed 1 July 2010 start date come and go, with no resolution to the confusion in sight.
Market report: Aussie biotechs defy wider market blues
13 November, 2010 by David BinningThe S&P/ASX 200 Heathcare Index managed to sneak into positive territory this week, adding to last week’s strong gains.
Avexa to buy 24 percent of Allied Medical
12 November, 2010 by David BinningTroubled HIV treatment developer Avexa will pay around $1.5 million to acquire up to 24 percent of Western Australia medical devices company Allied Medical under the terms of a deal revealed this week.
What is the R&D Tax Credit?
10 November, 2010 by Tim DeanThe R&D Tax Credit legislation has had a chequered past, going through multiple revisions and stalling before entering the Senate prior to the federal election.
Government names ‘experts’ to chart course for enabling technologies
05 November, 2010 by Staff WritersThe federal government has named the 21-strong expert advisory panel who will help chart the direction of its $38.2 million National Enabling Technologies Strategy.
Government announces $160 million for four new innovation funds
05 November, 2010 by Staff WritersThe federal government today announced the formation of four new funds with a combined war chest of $160 million to support Australian innovation.
Australia and China to build new nanotechnology lab
05 November, 2010 by David BinningThe governments of Australia and China have announced that they will jointly fund a new state-of-the-art nanotechnology laboratory in China.
Applications open for 14th round of CRCs
03 November, 2010 by Staff WritersFederal innovation Minister Senator Kim Carr today announced the opening of round 14 of the CRC ( cooperative research centres) program, inviting companies around Australia to partner up and submit their applications for funding.
Aussie biotech equities under perform wider market for Q1: PWC
28 October, 2010 by Staff WritersPricewaterhouseCoopers has released its Q1FY11 BioForum report on Australia’s life sciences and biotech equities, revealing that the sector went backwards slightly as the wider market advanced.
Hatchtech raises $6.3 million for Phase IIb head lice trial
26 October, 2010 by Staff WritersMelbourne biotech Hatchtech announced today that it has raised $6.3 million to fund Phase IIb clinical trials for its novel treatment for head lice.
Market report: Healthcare index ends the week up as AusBiotech 2010 draws to a close
22 October, 2010 by David BinningThe heavy back-slapping and self-congratulations at this week’s AusBiotech 2010 shindig in Melbourne may have rubbed off a little on the S&P/ASX 200 Healthcare Index, which managed to claw back most of last week’s losses.
Australian biotech for sale
22 October, 2010 by David BinningAny doubts as to the marketability of the Australian biotech and life sciences industries were thoroughly dispelled this week with 150 investors from more than 100 companies - foreign and Australian - attending AusBiotech’s Australasian Life Sciences Investment Summit in Melbourne as part of AusBiotech 2010.
